Literature DB >> 31268283

Acute Bacterial Meningitis: Challenges to Better Antibiotic Therapy.

Colin Kietzman1, Elaine Tuomanen1.   

Abstract

Bacterial meningitis is a medical emergency requiring highly bactericidal antibiotics to achieve cure. Many challenges exist to achieving optimal patient outcome. First, antibiotics must pass the blood brain barrier. Once in the subarachnoid space, achieving bactericidal therapy involves circumventing antibiotic resistance and, more commonly, antibiotic tolerance arising from the slow growth of bacteria in the nutrient poor cerebrospinal fluid. Finally, bactericidal therapy is most often bacteriolytic, and debris from lysis is highly inflammatory. Controlling damage from lytic products may require adjunctive therapy to prevent neuronal death. These challenges are an extreme example of the different requirements for treating infections in different body sites.

Entities:  

Keywords:  adjunctive therapy; autolysis; neuronal death; pneumococcus; tolerance

Mesh:

Substances:

Year:  2019        PMID: 31268283      PMCID: PMC6910910          DOI: 10.1021/acsinfecdis.9b00122

Source DB:  PubMed          Journal:  ACS Infect Dis        ISSN: 2373-8227            Impact factor:   5.084


  97 in total

Review 1.  Toll-like receptors in bacterial meningitis.

Authors:  Uwe Koedel
Journal:  Curr Top Microbiol Immunol       Date:  2009       Impact factor: 4.291

2.  Multiple antibiotic resistance in a bacterium with suppressed autolytic system.

Authors:  A Tomasz; A Albino; E Zanati
Journal:  Nature       Date:  1970-07-11       Impact factor: 49.962

Review 3.  Antibiotic tolerance among clinical isolates of bacteria.

Authors:  E Tuomanen; D T Durack; A Tomasz
Journal:  Antimicrob Agents Chemother       Date:  1986-10       Impact factor: 5.191

4.  Involvement of the relA gene in the autolysis of Escherichia coli induced by inhibitors of peptidoglycan biosynthesis.

Authors:  W Kusser; E E Ishiguro
Journal:  J Bacteriol       Date:  1985-11       Impact factor: 3.490

Review 5.  Toll-like receptors in health and disease in the brain: mechanisms and therapeutic potential.

Authors:  Mark L Hanke; Tammy Kielian
Journal:  Clin Sci (Lond)       Date:  2011-11       Impact factor: 6.124

6.  Dexamethasone in adults with bacterial meningitis.

Authors:  Jan de Gans; Diederik van de Beek
Journal:  N Engl J Med       Date:  2002-11-14       Impact factor: 91.245

7.  Isolation and characterization of vancomycin-tolerant Streptococcus pneumoniae from the cerebrospinal fluid of a patient who developed recrudescent meningitis.

Authors:  J A McCullers; B K English; R Novak
Journal:  J Infect Dis       Date:  2000-01       Impact factor: 5.226

8.  Bactericidal versus bacteriostatic antibiotic therapy of experimental pneumococcal meningitis in rabbits.

Authors:  W M Scheld; M A Sande
Journal:  J Clin Invest       Date:  1983-03       Impact factor: 14.808

9.  The induction of meningeal inflammation by components of the pneumococcal cell wall.

Authors:  E Tuomanen; H Liu; B Hengstler; O Zak; A Tomasz
Journal:  J Infect Dis       Date:  1985-05       Impact factor: 5.226

10.  Effects of Toll-like receptor 2 agonist Pam(3)CysSK(4) on inflammation and brain damage in experimental pneumococcal meningitis.

Authors:  Johann Sellner; Denis Grandgirard; Christian Gianinazzi; Regine M Landmann; Stephen L Leib
Journal:  J Neuroimmunol       Date:  2008-11-13       Impact factor: 3.478

View more
  1 in total

1.  Neuronal Damage and Neuroinflammation, a Bridge Between Bacterial Meningitis and Neurodegenerative Diseases.

Authors:  Kristine Farmen; Miguel Tofiño-Vian; Federico Iovino
Journal:  Front Cell Neurosci       Date:  2021-06-03       Impact factor: 5.505

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.